GlassScriptPhysician profile
Glen R Daughtry
NPI 1578556551
$21,551.23
in general payments reported to CMS, 2019-2025
68 companies · $3,718 in 2025
The $3,718 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,864 · 2020: $850 · 2021: $3,020 · 2022: $2,919 · 2023: $3,836 · 2024: $3,344 · 2025: $3,718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $6.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,891.68 |
| Education | $6.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,559.96 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $2,202.59 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $2,191.15 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $1,812.84 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,572.96 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Amgen INC. | $1,342.60 | 2019-2025 | Evenity, Repatha, Otezla |
| Lilly USA, LLC | $1,101.31 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $924.34 | 2019-2025 | |
| Amarin Pharma, INC. | $668.83 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $513.52 | 2019-2025 | Xarelto, Spravato |
| Axsome Therapeutics, INC. | $466.76 | 2023-2025 | Auvelity, Sunosi, Symbravo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $368.04 | 2019-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $338.17 | 2019-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $311.56 | 2024-2025 | Caplyta |
| Sanofi Pasteur INC. | $309.82 | 2019-2025 |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $309.17 | 2019-2025 | Eliquis, Camzyos |
| Dexcom, INC. | $293.71 | 2022-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $289.38 | 2019-2022 | |
| Exact Sciences Corporation | $266.52 | 2023-2025 | Cologuard Collection Kit |
| Eisai INC. | $248.04 | 2024-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $235.52 | 2022 | |
| Astellas Pharma US INC | $214.09 | 2020-2025 | Veozah, Myrbetriq |
| Otsuka America Pharmaceutical, INC. | $184.15 | 2020-2025 | Rexulti |
| Allergan, INC. | $175.02 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $161.80 | 2019-2023 | Proquad, Gardasil 9, Vaxneuvance |
| Nestle Healthcare Nutrition INC. | $156.76 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $149.46 | 2019-2024 | Trintellix |
| Abbott Laboratories | $145.02 | 2022-2025 | Freestyle Libre, Freestyle Libre 3 |
| Teva Pharmaceuticals USA, INC. | $138.71 | 2019-2025 | Austedo Xr, Austedo Xr, Airduo Digihaler |
| Ibsa Pharma INC. | $122.03 | 2020-2024 | Tirosint, Licart, Tirosint |
| Avanir Pharmaceuticals, INC. | $113.87 | 2019 | |
| Daiichi Sankyo INC. | $107.75 | 2019-2020 | |
| Lundbeck LLC | $93.36 | 2022-2025 | Rexulti |
| Esperion Therapeutics, INC. | $92.17 | 2023-2025 | Nexletol |
| Aimmune Therapeutics, INC. | $88.97 | 2024-2025 | Zenpep |
| Kowa Pharmaceuticals America, INC. | $84.58 | 2019-2022 | |
| Mylan Specialty L.P. | $73.84 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $72.90 | 2025 | Gemtesa |
| Mannkind Corporation | $67.08 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $64.22 | 2021 | |
| Phathom Pharmaceuticals, INC. | $59.92 | 2024-2025 | Voquezna |
| Cequr Corporation | $52.69 | 2023-2024 | Cequr Simplicity |
| Viatris Specialty LLC | $51.70 | 2025 | Yupelri |
| Xeris Pharmaceuticals, INC. | $50.85 | 2024-2025 | Gvoke Hypopen |
| Genentech USA, INC. | $49.02 | 2019-2022 | |
| Halozyme INC | $46.49 | 2023 | |
| Biogen, INC. | $45.95 | 2024-2025 | Leqembi |
| Regeneron Healthcare Solutions, INC. | $42.48 | 2020-2025 | Dupixent |
| Bayer Healthcare Pharmaceuticals INC. | $41.47 | 2022 | |
| Vanda Pharmaceuticals INC. | $41.30 | 2025 | Fanapt |
| Ironshore Pharmaceuticals INC. | $39.76 | 2019 | |
| Verona Pharma, INC. | $37.31 | 2025 | Ohtuvayre |
| Medtronic, INC. | $35.17 | 2021-2024 | Interstim |
| Ironwood Pharmaceuticals, INC | $34.75 | 2020-2022 | |
| Harmony Biosciences LLC | $31.23 | 2024 | |
| Cumberland Pharmaceuticals, INC. | $31.03 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $30.62 | 2023-2024 | Quviviq |
| Radius Health, INC. | $30.23 | 2024 | Tymlos |
| Opko Pharmaceuticals, LLC | $26.15 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $24.87 | 2024 | Uptravi, Opsumit |
| Inspire Medical Systems, INC. | $18.26 | 2024 | Inspire |
| Corium, LLC | $18.15 | 2022 | |
| Shield Therapeutics INC | $17.04 | 2023 | Accrufer |
| Horizon Therapeutics Plc | $14.86 | 2019 | |
| Assertio Therapeutics, INC. | $14.78 | 2019 | |
| Intra-Sana Laboratories | $13.49 | 2023 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Shire North American Group INC | $13.09 | 2019 | |
| Bardy Diagnostics, INC. | $6.00 | 2020 |
Drugs and devices associated with these payments
Farxiga $808Jardiance $637Trelegy Ellipta $636Wegovy $577Rybelsus $531Ozempic $531Vraylar $522Mounjaro $514Breztri $476Ubrelvy $449Airsupra $428Arexvy $373Eliquis $360Auvelity $358Qulipta $342Caplyta $312Leqembi $294Nurtec Odt $284Cologuard Collection Kit $267Fasenra $244Dexcom G6 Transmitter $236Rexulti $202Zepbound $197Evenity $190Repatha $186Otezla $174Menquadfi $173Paxlovid $171Leqvio $162Shingrix $159Prolia $154Zenpep $151Tirosint $149Vaxelis $143Xarelto $142Zavzpret $142Tradjenta $116Synjardy $116Xifaxan $104Linzess $103Prevnar 20 $95.38Comirnaty $95.38Nexletol $92.17Licart $86.07Stiolto Respimat $83.51Flublok Quadrivalent Northern Hemisphere $73.96Fluzone High-Dose $73.96Gemtesa $72.90Sunosi $67.75Spravato $67.68Freestyle Libre $64.67Camzyos $62.27Creon $60.63Voquezna $59.92Abrysvo $57.04Viberzi $54.19Cequr Simplicity $52.69Yupelri $51.70Gvoke Hypopen $50.85Veozah $49.26Xyosted $46.49Tlando $46.49Freestyle Libre 3 $43.95Fanapt $41.30Symbravo $40.80Entresto $38.22Ohtuvayre $37.31Austedo Xr $36.03Fluzone Quadrivalent Northern Hemisphere $35.27Bexsero $34.04Emgality $33.40Vascepa $33.00Prevnar 13 $32.85Trintellix $31.35Wakix $31.23Quviviq $30.62Tymlos $30.23Beyfortus $30.12Vaxneuvance $28.65Gardasil 9 $28.65Proquad $28.65Opsumit $24.87Uptravi $24.87Spiriva Respimat $21.64Dupixent $21.00Myrbetriq $19.33Interstim $19.28Inspire $18.26Kisunla $17.71Accrufer $17.04Saphnelo $15.58Airduo Digihaler $15.40Synthroid $13.63Glycate $13.49Reltone 200 Mg $13.49Reltone 400 Mg $13.49
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glen Daughtry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.